PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
35114189-0	2022	Nigericin exerts anticancer effects through inhibition of the SRC/STAT3/BCL-2 in osteosarcoma.	Nigericin	0-9	SRC proto-oncogene, non-receptor tyrosine kinase	Homo sapiens	62-65	
35114189-7	2022	Furthermore, bioinformatics predicted that Nigericin exerts anticancer effects through inhibiting SRC/STAT3 signaling pathway in osteosarcoma.	Nigericin	43-52	SRC proto-oncogene, non-receptor tyrosine kinase	Homo sapiens	98-101	
35114189-10	2022	In order to further elucidate the inhibitory effect of nigericin on SRC / STAT3 / Bcl-2 signal transduction mechanism, we established human osteosarcoma cancer cells stably expressing STAT3.	Nigericin	55-64	SRC proto-oncogene, non-receptor tyrosine kinase	Homo sapiens	68-71	
9124524-4	1997	Sodium propionate addition, NH4Cl prepulse, and nigericin addition, maneuvers that decrease intracellular pH in the absence of changes in extracellular pH, activated c-Src.	Nigericin	48-57	SRC proto-oncogene, non-receptor tyrosine kinase	Homo sapiens	166-171